MREO NASDAQ
Mereo BioPharma Group plc
1W: +2.6%
1M: +42.1%
3M: +20.0%
YTD: -25.6%
1Y: -81.5%
3Y: -71.9%
5Y: -84.2%
$0.38
+0.01 (+3.52%)
Weekly Expected Move ±14.3%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-28M
Net Income
+43.2% YoY
$-25M
Free Cash Flow
+23.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-67.8%
ROA-57.7%
ROIC6194.3%
Valuation
P/E-2.1
P/B2.1
EV/EBITDA-0.7
Leverage
Debt/Equity0.04
Current Ratio5.88
Interest Cov.-379.3x
Quality Scores
Piotroski F2/9
Altman Z-17.87
Beneish M0.00